Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 26, 2026
Assessment of pulmonary function in a mouse model of bronchopulmonary dysplasia by unrestrained whole-body plethysmography and the forced oscillation techniqueDavid E Surate Solaligue, Claudio Nardiello, José Alberto Rodríguez-Castillo, et al.
The Journal of Pediatrics|January 23, 2026
Respiratory Practices to Prevent or Treat Evolving Bronchopulmonary Dysplasia: A European SurveyMoniek van de Loo, Wes Onland, Jeroen Hutten, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 5, 2019
The genomic and clinical landscape of fetal akinesiaMatthias Pergande, Susanne Motameny, Özkan Özdemir, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 27, 2020
Correction: The genomic and clinical landscape of fetal akinesiaMatthias Pergande, Susanne Motameny, Özkan Özdemir, et al.
Neonatology|September 7, 2025
Management of Apnoea in Extremely Preterm Infants: A European SurveyAnna Lavizzari, G Jeroen Hutten, Christian Heiring, et al.
The Lancet. Respiratory Medicine|April 21, 2024
Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trialSascha Meyer, Johannes Bay, Axel R Franz, et al.
Eclinicalmedicine|December 8, 2025
Two-year outcomes after early postnatal high-dose fat-soluble enteral vitamin A supplementation in extremely low birth weight infants: follow-up of the NeoVitaA randomized controlled trialMartin Poryo, Ludwig Gortner, Johannes Bay, et al.
Eclinicalmedicine|November 10, 2025
Corrigendum to "Two-year outcomes after early postnatal high-dose fat-soluble enteral vitamin A supplementation in extremely low birth weight infants: follow-up of the NeoVitaA randomized controlled trial"Martin Poryo, Ludwig Gortner, Johannes Bay, et al.
The Lancet. Child & Adolescent Health|February 12, 2026
Automatic versus manual control of oxygen and neonatal clinical outcomes in extremely preterm infants: a multicentre, parallel-group, randomised, controlled, superiority trialAxel R Franz, Christian A Maiwald, Hendrik J Niemarkt, et al.
Pageof 10